Russell E. Scheffer
Child and Adolescent Psychiatry
1010 N Kansas St Ste 3049
Wichita, KS 67214
Wichita, KS 67214
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Lithium for the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Discontinuation Study.
Journal: Journal of the American Academy of Child and Adolescent Psychiatry
Published: February 21, 2018
A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders.
Journal: Journal of child and adolescent psychopharmacology
Published: October 17, 2017
Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients.
Journal: Journal of child and adolescent psychopharmacology
Published: March 24, 2017
Lithium in the Acute Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study.
Journal: Pediatrics
Published: August 20, 2015
Placebo-controlled trial of valproic Acid versus risperidone in children 3-7 years of age with bipolar I disorder.
Journal: Journal of child and adolescent psychopharmacology
Published: May 16, 2015
Review: second-generation antipsychotics improve response in paediatric bipolar disorder, but are associated with adverse events.
Journal: Evidence-based mental health
Published: November 22, 2011
Showing 1-6 of 6
Last Updated: 09/26/2026